MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,217,000 | -61.6% | 14,800 | -31.5% | 0.01% | -57.6% |
Q4 2021 | $3,169,000 | -5.2% | 21,600 | +14.3% | 0.03% | -2.9% |
Q3 2021 | $3,344,000 | +183.6% | 18,900 | +158.9% | 0.03% | +183.3% |
Q2 2021 | $1,179,000 | -29.8% | 7,300 | -25.5% | 0.01% | -33.3% |
Q1 2021 | $1,679,000 | -37.9% | 9,800 | -20.3% | 0.02% | -41.9% |
Q4 2020 | $2,702,000 | -8.6% | 12,300 | -30.9% | 0.03% | -24.4% |
Q3 2020 | $2,956,000 | +45.5% | 17,800 | 0.0% | 0.04% | +41.4% |
Q2 2020 | $2,032,000 | +66.3% | 17,800 | +11.9% | 0.03% | +20.8% |
Q1 2020 | $1,222,000 | -41.8% | 15,900 | -2.5% | 0.02% | -27.3% |
Q4 2019 | $2,100,000 | +69.5% | 16,300 | +2.5% | 0.03% | +43.5% |
Q3 2019 | $1,239,000 | -44.1% | 15,900 | -26.0% | 0.02% | -39.5% |
Q2 2019 | $2,215,000 | +108.4% | 21,500 | +48.3% | 0.04% | -34.5% |
Q1 2019 | $1,063,000 | +4.4% | 14,500 | -39.6% | 0.06% | -13.4% |
Q4 2018 | $1,018,000 | -13.6% | 24,000 | -4.0% | 0.07% | -10.7% |
Q3 2018 | $1,178,000 | -6.3% | 25,000 | -2.0% | 0.08% | -29.9% |
Q2 2018 | $1,257,000 | – | 25,500 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
Trexquant Investment LP | 42,879 | $223,000 | 0.03% |